The purpose of this study is to evaluate pharmacokinetics of sildenafil citrate in healthy male volunteers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
52
1 tablet of 100mg, once a day
to Assess Pharmacokinetics
AUC and Cmax in plasma
Time frame: 24h after drug administration
to Assess Safety
Adverse events, Physical exam, Vital sign, Laboratory, 12-lead-ECG
Time frame: 24h after administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.